Literature DB >> 18590940

Adaptation to a long term (4 weeks) arginine- and precursor (glutamate, proline and aspartate)-free diet.

John F Tharakan1, Yong M Yu, David Zurakowski, Rachel M Roth, Vernon R Young, Leticia Castillo.   

Abstract

BACKGROUND & AIMS: It is not known whether arginine homeostasis is negatively affected by a "long term" dietary restriction of arginine and its major precursors in healthy adults. To assess the effects of a 4-week arginine- and precursor-free dietary intake on the regulatory mechanisms of arginine homeostasis in healthy subjects.
METHODS: Ten healthy adults received a complete amino acid diet for 1 week (control diet) and following a break period, six subjects received a 4-week arginine, proline, glutamate and aspartate-free diet (APF diet). The other four subjects continued for 4 weeks with the complete diet. On days 4 and 7 of the first week and days 25 and 28 of the 4-week period, the subjects received 24-h infusions of arginine, citrulline, leucine and urea tracers.
RESULTS: During the 4-week APF, plasma arginine fluxes for the fed state, were significantly reduced. There were no significant differences for citrulline, leucine or urea fluxes. Arginine de novo synthesis was not affected by the APF intake. However, arginine oxidation was significantly decreased.
CONCLUSIONS: In healthy adults, homeostasis of arginine under a long term arginine- and precursor-free intake is achieved by decreasing catabolic rates, while de novo arginine synthesis is maintained.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590940      PMCID: PMC2574647          DOI: 10.1016/j.clnu.2008.04.014

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  22 in total

Review 1.  Whole-body protein and amino acid turnover in man: what can we measure with confidence?

Authors:  D J Millward; G M Price; P J Pacy; D Halliday
Journal:  Proc Nutr Soc       Date:  1991-08       Impact factor: 6.297

2.  Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling.

Authors:  L Castillo; L Beaumier; A M Ajami; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model.

Authors:  G N Thompson; P J Pacy; H Merritt; G C Ford; M A Read; K N Cheng; D Halliday
Journal:  Am J Physiol       Date:  1989-05

Review 4.  Arginine: new and exciting developments for an "old" amino acid.

Authors:  L Beaumier; L Castillo; Y M Yu; A M Ajami; V R Young
Journal:  Biomed Environ Sci       Date:  1996-09       Impact factor: 3.118

5.  Validation of the tracer-balance concept with reference to leucine: 24-h intravenous tracer studies with L-[1-13C]leucine and [15N-15N]urea.

Authors:  A E el-Khoury; N K Fukagawa; M Sánchez; R H Tsay; R E Gleason; T E Chapman; V R Young
Journal:  Am J Clin Nutr       Date:  1994-05       Impact factor: 7.045

6.  Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets.

Authors:  L Castillo; T E Chapman; M Sanchez; Y M Yu; J F Burke; A M Ajami; J Vogt; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

7.  Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.

Authors:  Anura V Kurpad; Meredith M Regan; Tony Raj; Jahnavi Vasudevan; Rebecca Kuriyan; Justin Gnanou; Vernon R Young
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045

8.  The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake.

Authors:  L Castillo; M Sánchez; T E Chapman; A Ajami; J F Burke; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Plasma arginine kinetics in adult man: response to an arginine-free diet.

Authors:  L Castillo; A Ajami; S Branch; T E Chapman; Y M Yu; J F Burke; V R Young
Journal:  Metabolism       Date:  1994-01       Impact factor: 8.694

10.  The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state.

Authors:  J T Clarke; D M Bier
Journal:  Metabolism       Date:  1982-10       Impact factor: 8.694

View more
  6 in total

1.  Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginine-free diets.

Authors:  Juan C Marini; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  J Nutr       Date:  2010-06-23       Impact factor: 4.798

Review 2.  Arginine de novo and nitric oxide production in disease states.

Authors:  Yvette C Luiking; Gabriella A M Ten Have; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

3.  De novo synthesis is the main source of ornithine for citrulline production in neonatal pigs.

Authors:  Juan C Marini; Barbara Stoll; Inka Cajo Didelija; Douglas G Burrin
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

4.  Ablation of Arginase II Spares Arginine and Abolishes the Arginine Requirement for Growth in Male Mice.

Authors:  Inka C Didelija; Mahmoud A Mohammad; Juan C Marini
Journal:  J Nutr       Date:  2017-07-05       Impact factor: 4.798

5.  Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.

Authors:  Sandra C van Calcar; Erin L MacLeod; Sally T Gleason; Mark R Etzel; Murray K Clayton; Jon A Wolff; Denise M Ney
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

6.  Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.

Authors:  Rahul Bohra; Wenzel Schöning; Jelena Klawitter; Nina Brunner; Volker Schmitz; Touraj Shokati; Ryan Lawrence; Maria Fernanda Arbelaez; Björn Schniedewind; Uwe Christians; Jost Klawitter
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.